Five things for pharma marketers to know: Wednesday, November 25, 2020
PhRMA sues over drug importation rule; Expert advisory panel outlines plan for vaccine access; Purdue pleads guilty to three felonies.
Roundup
Five things for pharma marketers to know: Tuesday, November 24, 2020
AstraZeneca vaccine results impress; U.S. to begin distributing Regeneron antibody therapy; Merck acquires OncoImmune, maker of a COVID treatment.
Five things for pharma marketers to know: Monday, November 23, 2020
Regeneron’s experimental coronavirus treatment receives emergency use approval; Pfizer/BioNTech request emergency use approval for COVID-19 vaccine; Vaccine could be distributed as soon as 24-hours after receiving approval.
Five things for pharma marketers to know: Friday, November 20, 2020
HHS pilot program brings rapid, POC coronavirus tests to five states; CDC: Americans should not travel for Thanksgiving; J&J makes a $100 million diversity pledge.
Five things for pharma marketers to know: Thursday, November 19, 2020
Pfizer/BioNTech vaccine proves safe and effective; COVID death and hospitalization numbers surge; Biden taps pharma lobbyist for administration.
Five things for pharma marketers to know: Wednesday, November 18, 2020
Amazon launches online pharmacy; J&J expect coronavirus vaccine trial data by Feb.; Sen. Rob Portman enrolls in J&J COVID-19 vaccine trial.
Five things for pharma marketers to know: Tuesday, November 17, 2020
FDA to approve Moderna, Pfizer COVID-19 vaccines for emergency use as quickly as possible; Moderna’s coronavirus vaccine is 94.5% effective; 65 WHO employees have contracted the virus.
Five things for pharma marketers to know: Monday, November 16, 2020
Biden’s COVID-19 task force to meet with drugmakers; More than 68,500 hospitalized with coronavirus on Friday; MM+M 40 Under 40 nominations are open.
Five things for pharma marketers to know: Friday, November 13, 2020
NYC public school system anticipates return to virtual learning; States prep for vaccination push; U.S. government partners with pharmacy chains on vaccine distribution.
Five things for pharma marketers to know: Thursday, November 12, 2020
CDC: Masks are a two-way street; Lawmakers urge DOJ to revise Purdue settlement; Fauci expects positive readout from Moderna vaccine trial.
Five things for pharma marketers to know: Wednesday, November 11, 2020
Six out of ten American will not get COVID-19 vaccine unless it reduces risk by 50%; FDA approves Lilly’s coronavirus antibody treatment; Obamacare unlikely to be struck down.
Five things for pharma marketers to know: Tuesday, November 10, 2020
Pfizer and BioNTech unveil “landmark” preliminary results for vaccine; Biden unveils members of COVID-19 team; Results for ViiV PrEP drug impress
Five things for pharma marketers to know: Monday, November 9, 2020
President-elect Joe Biden to name coronavirus task force team; Biogen’s Alzheimer’s drug receives thumbs-down from FDA advisory panel; MM+M Holiday Contest entries are open.
Five things for pharma marketers to know: Friday, November 6, 2020
More than 100,000 COVID-19 cases in U.S. in a single day; Regeneron’s coronavirus antibody treatment up for potential emergency use authorization; Biogen’s Alzheimer’s drug to receive FDA approval.
Five things for pharma marketers to know: Thursday, November 5, 2020
Biopharma analysts expect no drug-pricing legislation in election’s wake; Results could roil health and science policy; A new shortage of PPE.
Want to read more?
Please login or register first to view this content.
